Concurrent analysis of human equilibrative nucleoside transporter 1 and ribonucleotide reductase subunit 1 expression increases predictive value for prognosis in cholangiocarcinoma patients treated with adjuvant gemcitabine-based chemotherapy

BACKGROUND: The aim of this study was to investigate the predictive and prognostic values of intratumoural human equilibrative nucleoside transporter 1 (hENT1) and ribonucleotide reductase subunit 1 (RRM1) expression in advanced cholangiocarcinoma patients treated with adjuvant gemcitabine-based che...

Descripción completa

Detalles Bibliográficos
Autores principales: Sasaki, H, Murakami, Y, Uemura, K, Sudo, T, Hashimoto, Y, Kondo, N, Sueda, T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183840/
https://www.ncbi.nlm.nih.gov/pubmed/25032731
http://dx.doi.org/10.1038/bjc.2014.399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183840/
https://www.ncbi.nlm.nih.gov/pubmed/25032731
http://dx.doi.org/10.1038/bjc.2014.399

Ejemplares similares